International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)
NCT01567280 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8111
Last updated 2020-07-31
Summary
The study design consists of a cross-sectional survey on the clinical characteristics of patients with asthma and their level of asthma control and current quality of life, and on a prospective evaluation of the rate of switch from the uncontrolled/poorly controlled condition to the status of controlled asthma. Asthma control will be based on the Asthma Control Questionnaire scoring system, that has been fully validated for use in both clinical practice and clinical trials and has strong discriminative properties which means that it can detect small differences between patients with different levels of asthma control and it is very sensitive to within-patient change in asthma control over time.
Quality of life as a reflection of the control of the disease, will also be evaluated by means of the Mini Asthma Quality of Life Questionnaire scoring system.
Conditions
Sponsors & Collaborators
-
Chiesi Farmaceutici S.p.A.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2013-10-31
- Completion
- 2014-10-31
Countries
- Italy
Study Locations
More Related Trials
-
Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.
NCT00219323 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Patterns of Care in Mild Asthmatic Patients
NCT04598555 ·Status: COMPLETED
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma
NCT05155020 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cross-sectional Study for Identification and Description of Severe Asthma Patients
NCT02293265 ·Status: COMPLETED ·Phase: PHASE3
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
NCT02114034 ·Status: ACTIVE_NOT_RECRUITING
-
TNF Alpha in Refractory Asthma
NCT00276029 ·Status: COMPLETED ·Phase: NA
-
National Survey on Asthma
NCT00770250 ·Status: COMPLETED
-
Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain
NCT07013760 ·Status: COMPLETED
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
NCT06605885 ·Status: ACTIVE_NOT_RECRUITING
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.
NCT04438408 ·Status: UNKNOWN
-
An Investigation of Tumor Necrosis Factor (TNF)-Alpha in Asthma Using Biopsy Explants and Primary Bronchial Epithelial Cell Cultures
NCT01161303 ·Status: COMPLETED
-
Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France
NCT00812357 ·Status: COMPLETED
-
Factors for Predicting Severe Asthma Exacerbators in Adult Asthmatics: A Real Word- Effectiveness Study
NCT04563988 ·Status: COMPLETED
-
A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355
NCT01043276 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
NCT06422663 ·Status: COMPLETED
-
Efficacy, Safety, and Pharmacokinetics of QAW039
NCT01253603 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
NCT04181190 ·Status: COMPLETED
-
Tezepelumab PRO Study
NCT05922891 ·Status: COMPLETED
-
A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
NCT02567708 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Adherence to Treatment in Asthma Control
NCT01455545 ·Status: COMPLETED